Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia by Kantarjian Hagop, Oki Yasuhiro, Garcia-Manero Guillermo, Huang Xuelin, O'Brien Susan, Cortes Jorge, Faderl Stefan, Bueso-Ramos Carlos, Ravandi Farhad, Estrov Zeev, Ferrajoli Alessandra, Wierda William, Shan Jianqin, Davis Jan, Giles Francis, Saba Hussain I, Issa Jean-Pierre J in Blood (2007).

[PMID: 16882708] PubMed

Abstract

Discussed In Paper

Loading...

Dosing Information

No dosing information annotated.